Develops hypochlorous acid products for wound care and dermatological conditions.
Jun 2026Revenue $21.9M/yrExpenses $23.3M/yr
No trendCash runway ≈ 2.0 years from Jun 2026
Figures by year
When will Sonoma Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $21.9M and expenses $23.3M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $19.5M | $22.0M | −$2.46M |
| Mar 2025 | $14.3M | $18.0M | −$3.71M |
| Mar 2024 | $12.7M | $17.4M | −$4.70M |
| Mar 2023 | $13.3M | $17.8M | −$4.57M |
| Mar 2022 | $12.6M | $18.5M | −$5.89M |
| Mar 2021 | $18.6M | $22.1M | −$3.45M |
| Mar 2020 | $17.9M | $25.3M | −$7.39M |
| Mar 2019 | $19.0M | $30.2M | −$11.3M |
| Mar 2018 | $16.7M | $30.8M | −$14.2M |
| Mar 2017 | $12.8M | $25.8M | −$13.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.